arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Surgery Partners, Inc.

SGRY
$15.53 ▲ +0.61 (+4.09%) at close
Healthcare ·Services-General Medical & Surgical Hospitals, NEC ·USServices-General Medical & Surgical Hospitals, NEC
46 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
35
Health
Weak
Bearish
auto_awesome

Analytical Summary

Surgery Partners, Inc. faces fundamental challenges with weakness in Debt to Equity. The fundamentals warrant careful consideration of downside risks.

Market Cap $2.0B
Dividend Yield
Revenue Growth 4.5%
Op. Margin 8.1%
ROIC 3.1%
FCF / Share $-0.03
Trailing P/E
Price / Book 1.2x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

46-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$810.90M
↑ +4.5%
Net Income Profit after all expenses
$-35.90M
↑ +4.8%
Operating Margin Operating profit as % of sales
8.1%
↓ -36.9% 60th
FCF / Share Free cash flow per share
$-0.03
↑ +74.6%
Long-Term Debt Long-term obligations
$3.74B
↑ +33.2%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)

Health Breakdown

Profitability
45
Returns
39
Financial Health
34
Cash Quality
6

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 13 years · 46 quarters